149 RESPONSE TO COMBINATION THERAPY WITH ‘SHORTER DURATION’ ‘HALF DOSE’ PEGYLATED INTERFERON AND ENTECAVIR IN CHRONIC HEPATITIS B IN BANGLADESH

Journal of Hepatology ◽

10.1016/s0168-8278(12)60162-7 ◽

2012 ◽

Vol 56 ◽

pp. S65

Author(s):

M. Mahtab ◽

S.F. Akbar ◽

S. Rahman

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Combination Therapy ◽

Chronic Hepatitis B ◽

Pegylated Interferon ◽

Download Full-text

Combination Therapy of Pegylated Interferon alpha 2b (PegIFN) and Adefovir Dipivoxil (ADV) in Chronic Hepatitis B (CH-B) Patients Reduces the Reservoir of Transcriptionally Active cccDNA and Hepatitis B Surface Antigen (HBsAg)

Zeitschrift für Gastroenterologie ◽

10.1055/s-2005-862299 ◽

2005 ◽

Vol 43 (01) ◽

Author(s):

F Metzler ◽

K Wursthorn ◽

B Zoellner ◽

P Buggisch ◽

M Zankel ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Combination Therapy ◽

Chronic Hepatitis B ◽

Interferon Alpha ◽

Adefovir Dipivoxil ◽

Hepatitis B Surface Antigen ◽

Pegylated Interferon ◽

Pegylated Interferon Alpha ◽

Interferon Alpha 2B

Download Full-text

Sustained antiviral effects and clearance of hepatitis surface antigen after combination therapy with entecavir and pegylated interferon in chronic hepatitis B

Antiviral Therapy ◽

10.3851/imp3225 ◽

2018 ◽

Vol 23 (6) ◽

pp. 513-521 ◽

Author(s):

Satoru Hagiwara ◽

Naoshi Nishida ◽

Tomohiro Watanabe ◽

Hiroshi Ida ◽

Toshiharu Sakurai ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Combination Therapy ◽

Chronic Hepatitis B ◽

Surface Antigen ◽

Pegylated Interferon ◽

Antiviral Effects

Download Full-text

529 WEEK 12 HBSAG TITER DECLINE IS PREDICTIVE OF SVR IN CHRONIC HEPATITIS B PATIENTS RECEIVING PEGYLATED INTERFERON PLUS TENOFOVIR COMBINATION THERAPY

Journal of Hepatology ◽

10.1016/s0168-8278(12)60542-x ◽

2012 ◽

Vol 56 ◽

pp. S209-S210 ◽

Author(s):

P. Marcellin ◽

M. Martinot-Peignoux ◽

M. Lapalus ◽

O. Lada ◽

Q. Zhang ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Combination Therapy ◽

Chronic Hepatitis B ◽

Pegylated Interferon ◽

Download Full-text

Combination therapy with pegylated interferon alpha-2b and adefovir dipivoxil in HBeAg-positive chronic hepatitis B versus interferon alone: a prospective, randomized study

Journal of Huazhong University of Science and Technology [Medical Sciences] ◽

10.1007/s11596-014-1312-2 ◽

2014 ◽

Vol 34 (4) ◽

pp. 542-547 ◽

Author(s):

Yu-hua Liu ◽

Tao Wu ◽

Ning Sun ◽

Guang-li Wang ◽

Jian-zhi Yuan ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Combination Therapy ◽

Chronic Hepatitis B ◽

Adefovir Dipivoxil ◽

Randomized Study ◽

Pegylated Interferon ◽

Pegylated Interferon Alpha ◽

Interferon Alpha 2B ◽

Positive Chronic Hepatitis

Download Full-text

Comparison of pegylated interferon monotherapy and de novo pegylated interferon plus tenofovir combination therapy in patients with chronic hepatitis B

Infection and Drug Resistance ◽

10.2147/idr.s195144 ◽

2019 ◽

Vol Volume 12 ◽

pp. 845-854 ◽

Author(s):

Caixia Zheng ◽

Honghong Yan ◽

Jianyong Zeng ◽

Shaohang Cai ◽

Xiaolu Wu

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Combination Therapy ◽

Chronic Hepatitis B ◽

De Novo ◽

Pegylated Interferon ◽

Interferon Monotherapy

Download Full-text

Combination therapy based on pegylated interferon alfa improves the therapeutic response of patients with chronic hepatitis B who exhibit high levels of hepatitis B e-antigen at 24 weeks

Medicine ◽

10.1097/md.0000000000017022 ◽

2019 ◽

Vol 98 (36) ◽

pp. e17022 ◽

Author(s):

Yafei Zhang ◽

Wei Li ◽

Zhongping Liu ◽

Jun Ye ◽

Guizhou Zou ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Combination Therapy ◽

Chronic Hepatitis B ◽

Therapeutic Response ◽

Pegylated Interferon ◽

Interferon Alfa ◽

Hepatitis B E Antigen ◽

Pegylated Interferon Alfa

Download Full-text

Potential Efficacy of Pegylated Interferon-α and a Nucleos(t)ide Analogue as Combination Therapy for HBeAg-Positive Chronic Hepatitis B

Gut and Liver ◽

10.5009/gnl14256 ◽

2016 ◽

Vol 10 (4) ◽

pp. 611-616 ◽

Author(s):

Chung-Il Wi ◽

W. Ray Kim ◽

John B. Gross ◽

Linda M. Stadheim ◽

John J. Poterucha

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Combination Therapy ◽

Chronic Hepatitis B ◽

Pegylated Interferon ◽

Interferon Α ◽

Potential Efficacy ◽

Positive Chronic Hepatitis

Download Full-text

Combination therapy of pegylated interferon and lamivudine and optimal controls for chronic hepatitis B infection

International Journal of Dynamics and Control ◽

10.1007/s40435-017-0306-x ◽

2017 ◽

Vol 6 (1) ◽

pp. 354-368 ◽

Author(s):

Kalyan Manna ◽

Siddhartha P. Chakrabarty

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Combination Therapy ◽

Chronic Hepatitis B ◽

Pegylated Interferon ◽

Optimal Controls ◽

Hepatitis B Infection ◽

Chronic Hepatitis B Infection

Download Full-text

Lamivudine/pegylated interferon alfa-2b sequential combination therapy compared with lamivudine monotherapy in HBeAg-negative chronic hepatitis B

Journal of Gastroenterology and Hepatology ◽

10.1111/j.1440-1746.2007.05103.x ◽

2007 ◽

Vol 22 (10) ◽

pp. 1582-1588 ◽

Author(s):

Themistoklis Vassiliadis ◽

Konstantinos Tziomalos ◽

Kalliopi Patsiaoura ◽

Thomas Zagris ◽

Olga Giouleme ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Combination Therapy ◽

Chronic Hepatitis B ◽

Pegylated Interferon ◽

Interferon Alfa ◽

Lamivudine Monotherapy ◽

Sequential Combination ◽

Pegylated Interferon Alfa ◽

Negative Chronic Hepatitis

Download Full-text

A Randomized, Controlled Trial of Combination Therapy for Chronic Hepatitis B: Comparing Pegylated Interferon-α2b and Lamivudine with Lamivudine Alone

Annals of Internal Medicine ◽

10.7326/0003-4819-142-4-200502150-00006 ◽

2005 ◽

Vol 142 (4) ◽

pp. 240 ◽

Author(s):

Henry Lik-Yuen Chan ◽

Nancy Wai-Yee Leung ◽

Alex Yui Hui ◽

Vincent Wai-Sun Wong ◽

Choong-Tsek Liew ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Chronic Hepatitis ◽

Hepatitis B ◽

Combination Therapy ◽

Chronic Hepatitis B ◽

Controlled Trial ◽

Pegylated Interferon ◽

Randomized Controlled ◽

Interferon Α2b

Download Full-text